WEEKLY MEETINGS
Weekly Community Call: Please join us for the next OHDSI Community Call (Tuesday, April 6, 11 am ET) for an update on OHDSI Network Studies. We will have overview presentations from six community collaborators.
• Seng Chan You: Cancer Risk Between H2 Blockers
• Jenny Lane: MSKAI- Musculoskeletal adverse events following hormonal treatment for breast cancer: Cohort Diagnostics to establish feasibility
• Carmen Olga-Torre : Covid-19 pandEmic impacts on mental health Related conditions Via multi-database nEtwork: a LongitutinaL Observational study (CERVELLO)
• Aki Nishimura : Alpha-1 blocker for Palliating Inflammatory injury Severity (APIS) study
• Xintong Li : Calculating the background rates of adverse events of special interest (AESI) for the COVID vaccines
• Martijn Schuemie : Evaluating Use of Methods for Adverse Event Under Surveillance (EUMAEUS)
Many of you will have the calendar link in your OHDSI Teams environment. If not, you will need the specific meeting link to access the community call; it will also be posted in the main OHDSI Teams environment. As always, if you can’t make it, the recordings will be posted to both our Community Calls page and the General OHDSI Teams recordings folder.
The next OHDSI APAC Community Call will be this week and will focus on OMOP Projects. Scheduled presenters will be Yuan Lu (Comprehensive comparative effectiveness and safety of second-line antihypertensive agents: Utilizing the LEGEND principles to mobilize collaboration across the OHDSI APAC network) and Namki Hong (presentation TBA).
WEEKLY WORKING GROUP CALLS
GIS-Geographic Information System WG Meeting: Monday, April 5 at 10 am ET: (Meeting Link)
Meetings are traditionally scheduled for every Monday at 10 am ET. NOTE: this is a revised schedule.
OMOP CDM Oncology WG – Genomic Subgroup Meeting: Tuesday, April 6 at 9 am ET (Meeting Link)
Meetings are traditionally scheduled for every Tuesday at 9 am ET.
Common Data Model WG: Tuesday, April 6 at 1 pm ET: (Meeting Link )
Meetings are traditionally scheduled for the first and third Tuesdays of each month at 1 pm ET.
OMOP CDM Oncology WG – Outreach/Research Subgroup Meeting: Tuesday, April 6 at 3 pm ET: (Meeting Link)
Meetings are traditionally scheduled for the first and third Tuesday of each month at 3 pm ET.
Patient-Level Prediction/Pop. Level Estimation WG Meeting (Eastern Hemisphere): Wednesday, April 7 at 4 pm KST (2AM ET): (Meeting Link)
Meetings are traditionally scheduled for the first Wednesday of every month at 4 pm KST.
OMOP CDM Oncology WG – CDM/Vocabulary Subgroup Meeting: Thursday, April 8 at 1 pm ET: (Meeting Link)
Meetings are traditionally scheduled for every Thursday at 1 pm ET.
China Chapter WG: Friday, April 9 at 10 am ET (Meeting Link)
Meetings are traditionally scheduled for the second Friday of each month at 10 am ET. Note: this meeting does not take place in MS Teams.
Phenotype Development and Evaluation WG: Friday, April 9 at 1pm ET (Meeting Link)
Meetings are traditionally scheduled for the second and fourth Fridays of each month at 1 pm ET.
OHDSI SHOUTOUTS
Congratulations to the team of Jimyung Park, Seng Chan You, Eugene Jeong, Chunhua Weng, Dongsu Park, Jin Roh, Dong Yun Lee, Jae Youn Cheong, Jin Wook Choi, Mira Kang, and Rae Woong Park for this recent study in JMIR Informatics: A Framework (SOCRATex) for Hierarchical Annotation of Unstructured Electronic Health Records and Integration Into a Standardized Medical Database: Development and Usability Study.
Congratulations to the team of Hao Liu, Yuan Chi, Alex Butler, Yingcheng Sun, Chunhua Weng for this study published in the Journal of Biomedical Informatics: A Knowledge Base of Clinical Trial Eligibility Criteria.
Congratulations to Clair Blacketer, Frank DeFalco, Patrick Ryan and Peter Rijnbeek on this recent preprint posted to MedRxiv: Increasing Trust in Real-World Evidence Through Evaluation of Observational Data Quality. Community feedback is appreciated.
MORE OHDSI UPDATES
2021 OHDSI Symposium:
Please remember to hold the dates September 12-15, 2021 for this year’s symposium. Please note Registration for the Symposium will be open in early April! Please look for forum posts, information on our website and symposium emails with further information.
The call for participation for the Collaborator Showcase for this year’s symposium will post the 3rd week of April! Again, please look for information on the forum, website and through the symposium email manager. We look forward to receiving your great work to be considered for the showcase!
Thank you to everybody who participated in the CDM 2-hour breakout session last week to discuss preparation for CDM Version 5.4. Clair Blacketer will share a few thoughts on this meeting during tomorrow’s community call.
The April edition of “The Journey” newsletter was posted last week, and links to all of the papers and preprints discussed on the community calls over the last month, as well as updates on OHDSI work with the FDA, the new collaboration with HL7, advances in patient-level prediction, and much more.
Work groups listed on the OHDSI website: To get a snapshot of the work group meetings for the month, please visit Upcoming Working Group Calls – OHDSI
Accessing MSTeams : If you attended the 2020 OHDSI Symposium, you are already in the OHDSI teams environment. If you would like to be added to the OHDSI teams environment, please fill out this form: Join OHDSI Teams
If you are already in the OHDSI teams environment and you would like to join work groups in teams, please fill out this form: Join Workgroups, Chapters, and Studies
Teams Best Practices and Guidance : For some guidance on MS Teams, please log into OHDSI Teams and check out this channel located in the OHDSI Team Teams Best Practices and Guidance
**you can also find the document on our website ohdsi.org under “Collaborate with OHDSI in MS Teams.”
Please continue to collaborate in our MS Teams environment, check out the OHDSI website and forums, and follow us on all platforms, including Twitter and LinkedIn to get continued updates and information on everything happening in our community.